Lu YS, Lee KS, Chao TY, Tseng LM, et al. A Phase Ib study of alpelisib or buparlisib combined with tamoxifen plus goserelin in premenopausal women with HR-positive HER2-negative advanced breast cancer. Clin Cancer Res 2020 Jul 27. pii: 1078-0432.CCR-20-1008.
PMID: 32718997